Presentations & Interviews

    3QFY2024 Results and Investor Conference Call Video  
    Nyrada CEO James Bonner and SAB Chair Gary Housley interview with Proactive Investors  
    Nyrada CEO James Bonner interview with 180 Markets  
    Nyrada CEO James Bonner interview with Financial News Network  
    James Bonnar (CEO) speaks to Tony Locantro (Alto Capital) about Nyrada’s Phase I Cholesterol Lowering Study  
    Nyrada (ASX:NYR) CEO, James Bonnar presentation to ShareCafe’s Hidden Gems Webinar, September 2022  
    Presentation to ShareCafe Hidden Gems Webinar  
    Presentation to E&P Small Caps Health Care Conference  
    Corporate Presentation  
    Investor Roadshow Presentation  
    Presentation to Meet the CEO Life Sciences Edition  
    Nyrada (ASX:NYR) CEO, James Bonnar presents at the ASX Small and Mid-Cap Conference  
    Nyrada (NYR: ASX) CEO, James Bonnar interview with Andrew Scott (Proactive Investors) at the ASX Small and Mid-Cap Conference, September 2021  
    Nyrada (ASX:NYR) interview with Finance News Network, June 2021  
    Nyrada (ASX:NYR) CEO, James Bonnar provides update on lead drug development programs at Finance News Network CEO Showcase, February 2021  
    Nyrada (ASX:NYR) discusses collaboration with the Walter Reed Army Institute of Research and UNSW Sydney, February 2021  
    Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021  
    Presentation to 2020 Annual General Meeting of Shareholders  
    Pitt Street Research Interview with Nyrada CEO, Mr James Bonnar  

    Nyrada Inc - Hidden Gems Webinar Presentation  

    Nyrada July/August 2020 webinar recording: New Therapies for Cardiovascular and Neurological Diseases, August 2020  

    Nyrada Roadshow Corporate Presentation July/August 2020  
    Nyrada presents at the Reach Markets "Meet the CEO's" virtual event June 24, 2020  

    Nyrada Virtual Investor Event 30 April 2020  
    Nyrada Preclinical Program & Corporate Update Presentation  
    Nyrada Inc. Corporate Presentation February 2020  
    Nyrada (ASX:NYR) - new therapies for cardiovascular and neurological disorders  

    Nyrada Inc - Corporate Presentation  
    Nyrada (ASX:NYR) targeting cholesterol-lowering drug candidate